ID24568A - Kontrasepsi oral yang mengandung anti-estrogen plus progestin - Google Patents

Kontrasepsi oral yang mengandung anti-estrogen plus progestin

Info

Publication number
ID24568A
ID24568A IDW20000811A ID20000811A ID24568A ID 24568 A ID24568 A ID 24568A ID W20000811 A IDW20000811 A ID W20000811A ID 20000811 A ID20000811 A ID 20000811A ID 24568 A ID24568 A ID 24568A
Authority
ID
Indonesia
Prior art keywords
contains anti
oral contraception
estrogen plus
plus progestin
progestin
Prior art date
Application number
IDW20000811A
Other languages
English (en)
Indonesian (id)
Inventor
Michael Jay Gast
Christopher Paul Miller
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ID24568A publication Critical patent/ID24568A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
IDW20000811A 1997-11-06 1998-04-11 Kontrasepsi oral yang mengandung anti-estrogen plus progestin ID24568A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06

Publications (1)

Publication Number Publication Date
ID24568A true ID24568A (id) 2000-07-27

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000811A ID24568A (id) 1997-11-06 1998-04-11 Kontrasepsi oral yang mengandung anti-estrogen plus progestin

Country Status (28)

Country Link
EP (1) EP1051179B1 (hr)
JP (1) JP2001522798A (hr)
CN (1) CN1278732A (hr)
AR (1) AR016667A1 (hr)
AT (1) ATE304359T1 (hr)
AU (2) AU760540B2 (hr)
BG (1) BG104451A (hr)
BR (1) BR9813982A (hr)
CA (1) CA2307210A1 (hr)
CZ (1) CZ294155B6 (hr)
DE (1) DE69831605T2 (hr)
DK (1) DK1051179T3 (hr)
EA (1) EA200000492A1 (hr)
EE (1) EE04092B1 (hr)
ES (1) ES2246541T3 (hr)
GE (1) GEP20043290B (hr)
HR (1) HRP20000269A2 (hr)
HU (1) HUP0100293A3 (hr)
ID (1) ID24568A (hr)
IL (1) IL135621A0 (hr)
NO (1) NO20002167L (hr)
NZ (1) NZ503890A (hr)
PL (1) PL340623A1 (hr)
SK (1) SK6482000A3 (hr)
TR (1) TR200001268T2 (hr)
UA (1) UA68365C2 (hr)
WO (1) WO1999024027A2 (hr)
ZA (1) ZA9810136B (hr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
ATE245026T1 (de) * 1998-05-15 2003-08-15 Wyeth Corp 2-phenyl-1-(-(2-aminoethoxy)-benzyl -indol und estrogen als kombinationpräparate
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
EA005371B1 (ru) * 1999-09-13 2005-02-24 Уайт Глюкопиранозидные конъюгаты 2-(4-гидроксифенил)-1-[4-(2-амин-1-илэтокси)бензил]-1h-индол-5-олов
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
WO2003011282A1 (en) 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
SI1809602T1 (sl) 2004-10-27 2009-04-30 Janssen Pharmaceutica Nv Indolni derivati, uporabni kot modulatorji progesteronskega receptorja
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
RS56042B1 (sr) 2010-06-10 2017-09-29 Seragon Pharmaceuticals Inc Modulatori estrogenih receptora i njihove upotrebe
JP2015500346A (ja) 2011-12-14 2015-01-05 セラゴン ファーマシューティカルズ，インク． エストロゲン受容体モジュレーターおよびその使用
AU2016331065B2 (en) 2015-10-01 2021-04-29 Olema Pharmaceuticals, Inc. Tetrahydro-1H-pyrido(3,4-b)indole anti-estrogenic drugs
CN108495628B (zh) 2015-12-09 2022-01-11 伊利诺伊大学评议会 苯并噻吩基选择性雌激素受体下调剂
EP3454862A4 (en) 2016-05-10 2020-02-12 C4 Therapeutics, Inc. SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN REDUCTION
CN109562107A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的杂环降解决定子体
WO2017197046A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. C3-carbon linked glutarimide degronimers for target protein degradation
BR112018077136A2 (pt) 2016-07-01 2019-04-30 G1 Therapeutics, Inc. composto, e, métodos para tratar um distúrbio associado com proliferação celular anormal e para reduzir o efeito de quimioterapia em células saudáveis.
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
AR110728A1 (es) 2017-01-06 2019-04-24 G1 Therapeutics Inc Terapia combinada para el tratamiento del cáncer
US10208011B2 (en) 2017-02-10 2019-02-19 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators
EA201992768A1 (ru) 2017-06-29 2020-05-19 Г1 Терапьютикс, Инк. Морфологические формы g1t38 и способы их получения
EP3897631A4 (en) 2018-12-20 2022-11-23 C4 Therapeutics, Inc. TARGETED PROTEIN DEGRADATION
WO2024030968A1 (en) 2022-08-03 2024-02-08 Brystol-Myers Squibb Company Compounds for modulating ret protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
DE69707189T2 (de) * 1996-04-19 2002-06-20 American Home Prod Östrogene Verbindungen
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
EE04092B1 (et) 2003-08-15
AU2003204896B2 (en) 2006-06-15
WO1999024027A2 (en) 1999-05-20
DE69831605D1 (de) 2005-10-20
CZ294155B6 (cs) 2004-10-13
NO20002167D0 (no) 2000-04-27
DK1051179T3 (da) 2005-10-31
HUP0100293A2 (hu) 2001-10-28
ES2246541T3 (es) 2006-02-16
EP1051179B1 (en) 2005-09-14
ZA9810136B (en) 2000-05-05
SK6482000A3 (en) 2000-11-07
HRP20000269A2 (en) 2000-12-31
CZ20001661A3 (cs) 2000-12-13
CN1278732A (zh) 2001-01-03
NZ503890A (en) 2002-08-28
EA200000492A1 (ru) 2000-10-30
IL135621A0 (en) 2001-05-20
EP1051179A2 (en) 2000-11-15
PL340623A1 (en) 2001-02-12
AR016667A1 (es) 2001-07-25
WO1999024027A3 (en) 1999-07-15
TR200001268T2 (tr) 2001-01-22
GEP20043290B (en) 2004-07-26
CA2307210A1 (en) 1999-05-20
AU1303199A (en) 1999-05-31
EE200000211A (et) 2001-04-16
BR9813982A (pt) 2000-09-26
ATE304359T1 (de) 2005-09-15
NO20002167L (no) 2000-06-28
DE69831605T2 (de) 2006-06-14
UA68365C2 (en) 2004-08-16
HUP0100293A3 (en) 2002-12-28
JP2001522798A (ja) 2001-11-20
AU760540B2 (en) 2003-05-15
BG104451A (en) 2000-12-29

Similar Documents

Publication Publication Date Title
ID24568A (id) Kontrasepsi oral yang mengandung anti-estrogen plus progestin
EP1001702A4 (en) ORTHOSES
EP1043031A4 (en) MEDICINAL COMPOSITIONS WITH PROLONGED RELEASE
HUP0004183A3 (en) Plaster
DK1140109T3 (da) Trefaset oralt antikonceptionsmiddel
AU2003204896A1 (en) Anti-estrogen plus progestin containing oral contraceptives
HUP0103883A3 (en) New sustained release oral formulations
HUP0102864A2 (hu) Gyulladásgátló fogápolószer
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
HUP9904345A3 (en) Oral contraceptive
IL137541A0 (en) New contraceptive kit
ITFI970066V0 (it) Attacco ortodontico
AU135502S (en) Condom
DE29700260U1 (de) Kondom
GB9716124D0 (en) Condoms
DE29705376U1 (de) Mundschutzkondom
DE29801911U1 (de) Frontzahnwall
DE29720643U1 (de) Hysteroskop
DE29810866U1 (de) Kondom-Aufsetzgerät
TW332432U (en) Improved medicated plaster
DE29721018U1 (de) Cervicalstütze
DE29722623U1 (de) Condomabroller
UA1593S (uk) Контрацептив вагінальний
DE29721047U1 (de) Präservativ